Cologuard Adds Coverage
Exact Sciences is now an in-network provider of Cologuard with Anthem Blue Cross and Blue Shield in five additional states, the organization announced Wednesday. “As Cologuard’s in-network status grows in…
Category Archives: Biotech
Cellectar Issued New Patent
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent that covers CLR 1603, a phospholipid ether-paclitaxel conjugate, the company announced recently. “This first issued patent under our CLR CTX…
CDI Partners with Michael J. Fox Foundation
To provide resources for developing new therapies, Cellular Dynamics International, a FUJIFILM company, announced Wednesday a partnership with The Michael J. Fox Foundation for Parkinson’s Research. “Our partnership with The…
Stemina Rebrands Its Diagnostics
Stemina Biomarker Discovery Inc., is rebranding its diagnostics to more accurately represent its focus on neurological disorders, the company announced recently. According to a release, NeuroPointDX, a division of Stemina,…
40K Cologuard Tests Completed in Q1
Exact Sciences announced today that approximately 40,000 Cologuard tests were completed in the first quarter of 2016. “Our first quarter performance reflects sequential growth and another significant year-over-year increase, the result…
SHINE CEO Strives to Help Society
Greg Piefer is ambitious, to say the least. The CEO of SHINE Medical Technologies expects his company to create a reliable supply of the medical ingredients, including molybdenum-99, required by nearly…
Cellectar Raises $8M in Public Offering
Cellectar Biosciences‘ public offering raised $8 million, the company announced today. “We are pleased with the results of this offering, including the underwriter’s exercise of their full over-allotment option,” Cellectar…
Propeller Teams With Global Pharma Company
To improve adherence and care management for people living with COPD and asthma, Propeller Health today announced it will partner with global pharmaceutical company Boehringer Ingelheim. “We are excited to…
SHINE Earns Plant Construction Approval
SHINE Medical Technologies has received approval from the U.S. Nuclear Regulatory Commission (NRC) for construction of a 57,000 square-foot isotope manufacturing facility in Janesville, Wis., the company announced today. “This is the…
Exact Sciences’ Cologuard Coverage Expands
Exact Sciences’ Cologuard will now be covered as an in-network service for patients of Anthem BlueCross of California, the organization announced today. “This is a major milestone for members of Anthem…
